Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Tumor-Agnostic 1

Conditions

Recurrence 1Glioblastoma 1Astrocytoma 1

Interventions

Temozolomide 43Magnetic Resonance Spectroscopy 39Specimen Handling 29Radiotherapy 19Radiation 16Bevacizumab 14Biopsy 13Nivolumab 12Radiosurgery 11X-Rays 9Cyclophosphamide 9Carboplatin 8Nuclear Medicine Department, Hospital 7Irinotecan 7Ipilimumab 6Cisplatin 6AZD 6244 6Vincristine 5Topotecan 5Phantoms, Imaging 5Lomustine 5Etoposide 5CTLA-4 Antigen 5ulixertinib 4trametinib 4pembrolizumab 4olaparib 4erdafitinib 4dinutuximab 4Surveys and Questionnaires 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
AZD1390 × CNS × 30 days × Clear all
NCT03970447 2026-06-03

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting
2,250 enrolled
CNS

Glioblastoma, Recurrence

NCT06894979 2026-05-15

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Children's Oncology Group

Phase 1 Recruiting
54 enrolled
CNS

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡